In addition to her role as a Senior Member in Cancer Epidemiology, Dr. Giuliano is also the Founding Director for the Center for Infection Research in Cancer (CIRC) at Moffitt.
Her career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer in females, and has since evolved to encompass HPV and penile, anal, and oropharyngeal cancers in males, as well as other infectious diseases and their causal relationships with various cancers. Dr. Giuliano’s work has contributed significantly to our understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, and HPV vaccine protection against multiple diseases in females and males. She has also been actively involved in cancer epidemiology and prevention studies conducted among diverse populations in the U.S. and abroad and, as such, was a contributor to the 1999 Institute of Medicine report entitled, "The Unequal Burden of Cancer," and the 2007 International Agency for Research on Cancer (WHO-IARC) report which concluded for the first time that HPV is a cause of multiple cancers in women and men. Dr. Giuliano was involved in the completion of Phase I, II, and III HPV vaccine trials in females and was the PI for the Phase III HPV vaccine trial in males that led to gender-neutral HPV vaccination recommendations in the U.S. As one of the world’s leading experts in HPV research, Dr. Giuliano has spearheaded multiple epidemiologic studies of cervical and penile cancer incidence nationally and internationally, including the multinational HPV Infection in Men (HIM) Study. Dr. Giuliano is the author of more 250 peer-reviewed publications and has been the recipient of several large grants from the NIH and the CDC for research on HPV infection among men and women.
She serves as a manuscript reviewer for several journals, including the Journal of the National Cancer Institute, International Journal of Cancer, Journal of Infectious Diseases, and JAMA. Dr. Giuliano is a consultant for several large NIH-funded cervical cancer prevention programs, and she serves as an advisory board member to several large international research consortia.